Viropil Tablet 30’s

Description

Introduction to Viropil Tablet 30’s

Viropil Tablet 30’s is a prescription antiretroviral medicine containing Dolutegravir, Lamivudine, and Tenofovir Disoproxil Fumarate. Doctors use this combination to manage Human Immunodeficiency Virus type 1 (HIV-1) infection in adults and children who meet the required weight criteria, including patients weighing 40 kg or more.

Dolutegravir belongs to the integrase strand transfer inhibitor (INSTI) class. It blocks the HIV integrase enzyme, which the virus needs to insert its genetic material into human cells. Lamivudine and Tenofovir Disoproxil Fumarate belong to the nucleoside/nucleotide reverse transcriptase inhibitor (NRTI) group. They interfere with HIV reverse transcriptase and help prevent the virus from making new copies of itself.

As a result, Viropil Tablet 30’s helps reduce HIV viral replication and supports immune function. However, the medicine does not eliminate HIV from the body. Therefore, continue taking it exactly as prescribed, even if you feel healthy.

Uses of Viropil Tablet 30’s

Viropil Tablet 30’s is used for:

• HIV-1 infection: It helps control HIV-1 infection in eligible adults and children weighing 40 kg or more.

Your healthcare professional will determine whether this combination is suitable based on your medical history, current medicines, and treatment requirements.

Therapeutic Benefits of Viropil Tablet 30’s

Viropil Tablet 30’s combines three antiretroviral medicines that target HIV replication through different mechanisms.

Dolutegravir blocks the integrase enzyme, while Lamivudine and Tenofovir Disoproxil Fumarate interfere with reverse transcriptase. Therefore, the combination helps reduce the production of new HIV particles.

Effective antiretroviral treatment can lower the viral load and support the recovery or maintenance of CD4 immune cells. As a result, it can help reduce the risk of HIV-related illnesses and complications when taken consistently as part of appropriate HIV care.

However, treatment does not guarantee that HIV transmission cannot occur. Therefore, continue following your healthcare professional’s recommendations for reducing the risk of HIV transmission.

Who Should Not Take Viropil Tablet 30’s?

Do not take Viropil Tablet 30’s if you have previously experienced an allergic reaction to Dolutegravir, Lamivudine, Tenofovir Disoproxil Fumarate, or any other ingredient in the medicine.

Your doctor may need to modify or closely monitor treatment if you have certain medical conditions. Therefore, inform your healthcare professional if you have or previously had:

• Kidney disease
• Liver disease or chronic Hepatitis B
• Pancreatitis
• Lactic acidosis
• Bone disease
• Osteonecrosis
• Previous bone fractures
• Other serious medical conditions

Moreover, tell your doctor about any unusual symptoms that develop during treatment.

Monitoring During Viropil Treatment

Your healthcare professional may recommend regular medical check-ups and laboratory tests during treatment.

Depending on your health history, monitoring may include:

• Kidney function
• Liver function
• Blood counts
• Bone health
• Other tests considered necessary by your doctor

Regular monitoring helps your healthcare team identify potential complications and assess how well your treatment is working.

Viropil Tablet 30’s and Pregnancy

Inform your doctor if you are pregnant, planning to become pregnant, or think you may be pregnant. Your healthcare professional can evaluate your treatment and recommend the most appropriate HIV management plan.

If you are breastfeeding, discuss this with your doctor. Because HIV can pass from mother to baby through breast milk, your healthcare professional will provide guidance on feeding and HIV treatment.

Drug Interactions with Viropil Tablet 30’s

Viropil Tablet 30’s can interact with certain medicines and supplements. Therefore, tell your doctor about everything you take, including:

• Prescription medicines
• Over-the-counter medicines
• Vitamins
• Mineral supplements
• Herbal products
• Other antiretroviral medicines

Some medicines can change how Viropil works or increase the risk of side effects. Therefore, do not start or stop another medicine without discussing it with your healthcare professional.

How to Take Viropil Tablet 30’s

Take Viropil Tablet 30’s exactly according to your doctor’s prescription.

• Take the medicine orally with water.
• Take it at approximately the same time every day.
• Swallow the tablet whole.

• Do not chew, crush, dissolve, or break the tablet unless your doctor specifically instructs you to do so.

• Follow the prescribed dose and treatment duration.
• Do not stop treatment on your own.

Consistent daily treatment is important for maintaining control of HIV. Missing doses can reduce treatment effectiveness and may contribute to the development of drug resistance.

What to Do If You Miss a Dose

If you forget to take Viropil Tablet 30’s, take the missed dose when you remember unless it is almost time for your next scheduled dose.

If the next dose is due soon, skip the missed dose and return to your regular schedule. Do not take an extra tablet to compensate for a missed dose unless your doctor specifically tells you to do so.

HIV Transmission and Viropil Tablet 30’s

Viropil Tablet 30’s helps control HIV but does not by itself eliminate the possibility of HIV transmission.

Therefore, follow recommended HIV prevention measures, including safer-sex practices and other precautions advised by your healthcare professional. Do not share needles, syringes, razors, toothbrushes, or other personal items that may come into contact with blood.

Storage of Viropil Tablet 30’s

Store Viropil Tablet 30’s according to the storage instructions provided on the product packaging.

• Store at temperatures up to 30°C, unless the product label specifies otherwise.
• Keep the medicine away from excessive heat and moisture.
• Protect the tablets from direct light.
• Keep the medicine in its original packaging.
• Store it out of reach of children and pets.
• Do not use the medicine after its expiry date.